Innovating Hepatology Care: Integrating Chatbots for Customized Treatment Strategies
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S319
DOI: 10.1055/s-0044-1783470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von R. M. Ram mohan und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Chatbots like ChatGPT and Google Bard have significantly impacted healthcare, particularly hepatology, enhancing liver disease diagnosis and treatment. These advanced solutions interpret ultrasound images, analyze samples, streamline administrative tasks, and aid in medical imaging and device automation. They have considerably improved hepatology disorder management by enabling personalized treatments and side-effect predictions. Integrating these AI tools provides patients with tailored treatment evaluations, promoting informed decision-making. However, the effectiveness of these chatbots still warrants further scrutiny.
Methods
The study evaluated the precision of two prominent Chat Bots – Chat GPT and Google BARD – in addressing medical management queries. Both bots were tasked with a series of questions, and their responses were evaluated on a 1-10 Likert scale, with 1 indicating utmost accuracy. Two unbiased evaluators examined each bot's responses to ensure objective evaluation. The research aimed to provide insight into these chatbots' capabilities via a structured performance appraisal, focusing on accuracy and dependability. The dual-evaluator system and the Likert scale approach helped minimize possible bias, lending credibility to the findings.
Results
Our research contrasted the effectiveness of Chat GPT and Google BARD in the realm of liver disease management. Chat GPT excelled, scoring 74% in the accuracy of information compared to Google BARD's 49% (p=0.015) and 48% vs.29% in medical information reliability (p=0.032). This study emphasizes the critical role of accuracy and dependability in developing liver disease-oriented chatbots. While Chat GPT displayed impressive performance, indicating its potential as a reliable tool, it also underscored the necessity for continued research and development in this field.
Conclusions
This research revealed the relative strengths of Chat GPT and Google Bard in liver disease management, with Chat GPT outperforming in both accuracy and reliability. As AI technologies continue to permeate healthcare, ensuring their accuracy is crucial. While Chat GPT demonstrated promising potential as a reliable hepatology tool, it also highlighted the continuous need for research and development in this domain. The significant disparity in performance emphasizes the importance of rigorous testing and validation before integrating AI tools into medical practice. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
mohan, R. M. R., Joy, M., Magam, S. G., Natt, D., Magam, S. R., Pannikodu, L., Desai, J., & Mustacchia, P. (2024). Innovating Hepatology Care: Integrating Chatbots for Customized Treatment Strategies. Endoscopy, 56(S 02 S 02), S319. https://doi.org/10.1055/s-0044-1783470
Vancouver
mohan RMR, Joy M, Magam SG, Natt D, Magam SR, Pannikodu L, et al. Innovating Hepatology Care: Integrating Chatbots for Customized Treatment Strategies. Endoscopy. 2024;56(S 02 S 02):S319. doi:10.1055/s-0044-1783470
BibTeX
@article{mohan2024,
author = {mohan, R. M. Ram and Joy, M. and Magam, S. G. and Natt, D. and Magam, S. R. and Pannikodu, L. and Desai, J. and Mustacchia, P.},
title = {Innovating Hepatology Care: Integrating Chatbots for Customized Treatment Strategies},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S319},
doi = {10.1055/s-0044-1783470}
}
EUVIMED